Novel, potent, and orally bioavailable phosphinic acid inhibitors of the hepatitis C virus NS3 protease.

[1]  J. R. Somoza,et al.  Synthesis and resolution of diethyl (1S,2S)-1-amino-2-vinylcyclopropane-1-phosphonate for HCV NS3 protease inhibitors , 2009 .

[2]  W. Delaney,et al.  Discovery of novel phosphonate derivatives as hepatitis C virus NS3 protease inhibitors. , 2009, Bioorganic & Medicinal Chemistry Letters.

[3]  J. Sheldon,et al.  Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection , 2007, Expert opinion on investigational drugs.

[4]  D. Häussinger,et al.  Subversion of innate host antiviral strategies by the hepatitis C virus. , 2007, Archives of biochemistry and biophysics.

[5]  S. Zeuzem,et al.  SCH 503034, a novel hepatitis C virus protease inhibitor, plus pegylated interferon alpha-2b for genotype 1 nonresponders. , 2007, Gastroenterology.

[6]  S. Savvides,et al.  Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase. , 2007, Journal of medicinal chemistry.

[7]  S. Zeuzem,et al.  Rapid decline of viral RNA in hepatitis C patients treated with VX-950: a phase Ib, placebo-controlled, randomized study. , 2006, Gastroenterology.

[8]  Xudong Wei,et al.  Efficient large-scale synthesis of BILN 2061, a potent HCV protease inhibitor, by a convergent approach based on ring-closing metathesis. , 2006, The Journal of organic chemistry.

[9]  C. Brochu,et al.  Potent inhibitors of the hepatitis C virus NS3 protease: design and synthesis of macrocyclic substrate-based beta-strand mimics. , 2004, The Journal of organic chemistry.

[10]  M. Fried,et al.  Treatment of chronic hepatitis C infection with peginterferons plus ribavirin. , 2004, Seminars in liver disease.

[11]  Steven R. LaPlante,et al.  An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus , 2003, Nature.

[12]  P. Bonneau,et al.  Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection. , 2003, Angewandte Chemie.

[13]  Hepatitis C Virus-Encoded Enzymatic Activities and Conserved RNA Elements in the 3′ Nontranslated Region Are Essential for Virus Replication In Vivo , 2000, Journal of Virology.

[14]  J. Ziller,et al.  Synthesis and Applications of RuCl2(CHR‘)(PR3)2: The Influence of the Alkylidene Moiety on Metathesis Activity , 1996 .

[15]  R. G. Hall,et al.  Phosphinic acid analogues of GABA. 2. Selective, orally active GABAB antagonists. , 1995, Journal of medicinal chemistry.

[16]  G. M. Kosolapoff,et al.  Preparation and Determination of Apparent Dissociation Constants of Some Alkylphosphonic and Dialkylphosphinic Acids1 , 1953 .